A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer

NCT00003683 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

NCT00980213 ·Status: COMPLETED

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

NCT00077974 ·Status: COMPLETED ·Phase: PHASE2

Study In Patients With Kidney Cancer Treated With Sutent

NCT00873210 ·Status: COMPLETED

Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00496756 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

NCT01444807 ·Status: UNKNOWN ·Phase: PHASE2

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

NCT00727532 ·Status: TERMINATED ·Phase: NA

An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy

NCT00538772 ·Status: WITHDRAWN

A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

NCT05858749 ·Status: COMPLETED

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

NCT00016939 ·Status: COMPLETED ·Phase: PHASE2

Optimization of Management for Sporadic Bilateral Renal Cell Carcinoma

NCT06369519 ·Status: COMPLETED

The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs

NCT05159245 ·Status: RECRUITING ·Phase: PHASE2

BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer

NCT00040989 ·Status: WITHDRAWN ·Phase: PHASE2

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

NCT00098618 ·Status: TERMINATED ·Phase: PHASE2

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

NCT04535687 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

NCT00054886 ·Status: COMPLETED ·Phase: PHASE2

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

NCT00053820 ·Status: COMPLETED ·Phase: PHASE3

S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer

NCT00058318 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma

NCT02689167 ·Status: UNKNOWN ·Phase: PHASE2

Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

NCT00586105 ·Status: COMPLETED ·Phase: PHASE3

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

NCT04375150 ·Status: COMPLETED

SUTENT® In The First Line Treatment Of Renal Cell Carcinoma

NCT00460798 ·Status: COMPLETED

Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries

NCT04669366 ·Status: COMPLETED

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

NCT01835158 ·Status: COMPLETED ·Phase: PHASE2

Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma

NCT00848640 ·Status: COMPLETED ·Phase: PHASE2